跳至主要内容
临床试验/DRKS00025923
DRKS00025923已完成不适用

Influence of sex hormones on Calcitonin Gene-Related Peptide (CGRP) in peripheral blood and tear fluid in migraine patients

Charité Campus Charité Mitte0 个研究点目标入组 240 人开始时间: 2021年7月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • •Inclusion Criteria - Migraine Groups:
  • •- Confirmed episodic migraine according to the International Headache Society (IHS) criteria
  • •- At least 4 migraine attacks in the 28 days prior to study inclusion.
  • •Inclusion criteria - COC groups:
  • •- Taking a COC for at least 3 months at a stable dose and on a conventional cycle (21 days of intake and 7 days off)
  • •Inclusion criteria - women without a COC:
  • •- Regular menstrual cycle (stable cycle length +-2 days over the last 3 cycles).
  • •Inclusion criteria - postmenopausal groups:
  • •- last menstrual period at least 5 years ago.

排除标准

  • •- BMI < 17 or above 30 kg/m2
  • •- History of gynecological or urological disease
  • •- History of other headache disorder (except max. 2 days tension-type headache/month)
  • •- Intake of migraine prophylactic medication
  • •- Pregnancy or lactation
  • •- Continuous hormonal contraception without hormone-free interval.

研究者

发起方
Charité Campus Charité Mitte

相似试验